Al-Thani, Mohammed Bin HamedSubramanian, MuruganHalabi, NajeebBujassoum Al Bader, SalhaShan, JingxuanAl-Rumaihi, Khalid RashidQoronfleh, M. WalidLashuel, Hilal A.Chouchane, Lotfi2025-06-262025-06-262025-06-25202510.1016/s1470-2045(25)00132-9https://infoscience.epfl.ch/handle/20.500.14299/251609Qatar's cancer care strategy is shaped by the National Cancer Strategy (2011) and subsequent frameworks 2017–22, leading to the Qatar Cancer Plan 2023–2026. These initiatives emphasise prevention, early detection, and evidence-based management to reduce the effects of cancer on patients and the health-care system. Investments in advanced medical infrastructure, cutting-edge technology, and specialised professionals have considerably strengthened cancer care. However, challenges remain, including late-stage diagnoses and gaps in public awareness, which underscores the need for enhanced education and global collaboration. Precision medicine, public health initiatives, and research-driven policies position Qatar as a regional leader in oncology. By leveraging its robust health-care and research ecosystem, Qatar aims to advance cancer prevention, diagnosis, and treatment. Aligned with WHO Eastern Mediterranean region goals, the country strives to establish a model of excellence in oncological services.entext::journal::journal article::review article